109 related articles for article (PubMed ID: 15142184)
1. Brachytherapy: the surgeon's perspective.
Henderson A; Sooriakumaran P; Laing RW; Langley SE
BJU Int; 2004 May; 93(7):1118. PubMed ID: 15142184
[No Abstract] [Full Text] [Related]
2. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
3. Urinary symptoms and prostate cancer treatment.
Health News; 2004 Jun; 10(6):2. PubMed ID: 15199892
[No Abstract] [Full Text] [Related]
4. State-of-the-art: prostate LDR brachytherapy.
Voulgaris S; Nobes JP; Laing RW; Langley SE
Prostate Cancer Prostatic Dis; 2008; 11(3):237-40. PubMed ID: 18364676
[TBL] [Abstract][Full Text] [Related]
5. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
Sarosdy MF
Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.
Williams SG; Millar JL; Duchesne GM; Dally MJ; Royce PL; Snow RM
Radiother Oncol; 2004 Oct; 73(1):33-8. PubMed ID: 15465143
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy: the surgeon's perspective.
O'Reilly PH
BJU Int; 2004 Jan; 93(1):4-5. PubMed ID: 14678356
[No Abstract] [Full Text] [Related]
8. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
9. Summary of simultaneous irradiation for prostate cancer.
Critz FA
Urology; 2004 Oct; 64(4):633-6. PubMed ID: 15491686
[No Abstract] [Full Text] [Related]
10. Prostate radiotherapy is associated with second cancers in many organs, not just the colorectum.
Brenner DJ; Hall EJ; Curtis RE; Ron E
Gastroenterology; 2005 Aug; 129(2):773-4; author reply 774-5. PubMed ID: 16083746
[No Abstract] [Full Text] [Related]
11. Re: Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
Deger S
J Urol; 2004 Sep; 172(3):1198; author reply 1198. PubMed ID: 15311075
[No Abstract] [Full Text] [Related]
12. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
14. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
Klein EA; Ciezki J; Kupelian PA; Mahadevan A
Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801
[TBL] [Abstract][Full Text] [Related]
15. Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity.
Eapen L; Kayser C; Deshaies Y; Perry G; E C; Morash C; Cygler JE; Wilkins D; Dahrouge S
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1392-4. PubMed ID: 15275724
[TBL] [Abstract][Full Text] [Related]
16. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T
Jpn J Clin Oncol; 2006 May; 36(5):285-9. PubMed ID: 16698803
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with the frequency of self-intermittent catheterization after prostate brachytherapy.
Schwartz DJ; Schild SE; Wong WW; Vora SA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):60-3. PubMed ID: 15629594
[TBL] [Abstract][Full Text] [Related]
19. Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
Gutman S; Merrick GS; Butler WM; Wallner KE; Allen Z; Galbreath RW; Adamovich E
BJU Int; 2006 Jan; 97(1):62-8. PubMed ID: 16336330
[TBL] [Abstract][Full Text] [Related]
20. [The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity].
Pommier P; Delannes M; LeFloch O; Bernier V; Baron MH; Thomas L; Malet C; Bonnet J; Louisot P; Aletti P; Goubard O; Chemin A; Chirat F; Lebivic S; Montbarbon X; Bachaud JM; Votron L; Lasbareilles O; Desmettre O; Bringeon G; Gassa F; Peiffert D
Cancer Radiother; 2006 Dec; 10(8):559-64. PubMed ID: 16959520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]